BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11169784)

  • 1. [(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites.
    Fischman AJ; Bonab AA; Babich JW; Livni E; Alpert NM; Meltzer PC; Madras BK
    Synapse; 2001 Mar; 39(4):332-42. PubMed ID: 11169784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.
    Madras BK; Gracz LM; Meltzer PC; Liang AY; Elmaleh DR; Kaufman MJ; Fischman AJ
    Synapse; 1998 Jun; 29(2):105-15. PubMed ID: 9593101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
    Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
    J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT.
    Bonab AA; Fischman AJ; Alpert NM
    J Nucl Med; 2000 Jun; 41(6):1086-92. PubMed ID: 10855640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain.
    Madras BK; Meltzer PC; Liang AY; Elmaleh DR; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):93-104. PubMed ID: 9593100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
    Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
    Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
    Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
    Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
    Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM
    J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
    Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
    J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
    Malison RT; Vessotskie JM; Kung MP; McElgin W; Romaniello G; Kim HJ; Goodman MM; Kung HF
    J Nucl Med; 1995 Dec; 36(12):2290-7. PubMed ID: 8523122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
    Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
    Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's.
    Gleave JA; Farncombe TH; Saab C; Doering LC
    Nucl Med Biol; 2011 Jul; 38(5):741-9. PubMed ID: 21718949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography.
    Xing D; Chen P; Keil R; Kilts CD; Shi B; Camp VM; Malveaux G; Ely T; Owens MJ; Votaw J; Davis M; Hoffman JM; BaKay RA; Subramanian T; Watts RL; Goodman MM
    J Med Chem; 2000 Feb; 43(4):639-48. PubMed ID: 10691690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease.
    Prunier C; Payoux P; Guilloteau D; Chalon S; Giraudeau B; Majorel C; Tafani M; Bezard E; Esquerré JP; Baulieu JL
    J Nucl Med; 2003 May; 44(5):663-70. PubMed ID: 12732666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter imaging with fluorine-18-FPCIT and PET.
    Kazumata K; Dhawan V; Chaly T; Antonini A; Margouleff C; Belakhlef A; Neumeyer J; Eidelberg D
    J Nucl Med; 1998 Sep; 39(9):1521-30. PubMed ID: 9744335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.